{"publisher":"Kisspeptin Co","product":"Kisspeptin","preparedAt":"2026-11-07","reviewStatus":"Research drafts; medical review has not been claimed","facts":[{"label":"Research finding 1","text":"In the women’s HSDD crossover trial,32 women completed both visits involving acute IV kisspeptin 54 or placebo and neuroimaging measurements.","href":"https://pubmed.ncbi.nlm.nih.gov/36287566/"},{"label":"Research finding 2","text":"The women’s study found changes in sexual/attraction brain processing, rather than demonstrating a durable cure for HSDD.","href":"https://pubmed.ncbi.nlm.nih.gov/36287566/"},{"label":"Research finding 3","text":"In the men’s HSDD crossover trial,32 men completed both visits; acute IV kisspeptin 54 changed neural processing and some secondary physiological/behavioral measures.","href":"https://pubmed.ncbi.nlm.nih.gov/36735255/"},{"label":"Research finding 4","text":"The 2014 IVF study administered subcutaneous kisspeptin 54 to 53 women after controlled ovarian stimulation; mature eggs and subsequent pregnancies were observed.","href":"https://pubmed.ncbi.nlm.nih.gov/25036713/"}],"sources":[{"title":"Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial.","href":"https://pubmed.ncbi.nlm.nih.gov/36287566/"},{"title":"Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial.","href":"https://pubmed.ncbi.nlm.nih.gov/36735255/"},{"title":"Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization.","href":"https://pubmed.ncbi.nlm.nih.gov/25036713/"},{"title":"Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks","href":"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks"}],"guides":[{"title":"Kisspeptin, diabetes and low testosterone: what a five-person study establishes","url":"https://kisspeptinco.com/research-guides/kisspeptin-diabetes-low-testosterone-proof-of-concept","description":"Read the selected metabolic-population experiment as proof of concept rather than a demonstrated long-term treatment.","date":"2026-11-07"},{"title":"A kisspeptin challenge test is not the same as treatment","url":"https://kisspeptinco.com/research-guides/kisspeptin-diagnostic-challenge-versus-therapy","description":"Understand the congenital-hypogonadism diagnostic study and why distinguishing groups does not prove a therapeutic benefit.","date":"2026-11-07"},{"title":"Why baseline estradiol matters when reading kisspeptin research","url":"https://kisspeptinco.com/research-guides/kisspeptin-estradiol-cycle-context","description":"A small women’s physiology experiment shows why hormone context belongs beside a reported LH response.","date":"2026-11-07"},{"title":"Kisspeptin and IVF: egg maturation is a specific research question","url":"https://kisspeptinco.com/research-guides/kisspeptin-ivf-egg-maturation-evidence","description":"Understand the specialist kisspeptin-54 IVF studies without translating them into general fertility claims.","date":"2026-11-07"},{"title":"Kisspeptin in men with low sexual desire: what does “56%” mean?","url":"https://kisspeptinco.com/research-guides/kisspeptin-men-desire-arousal-endpoints","description":"Put the acute kisspeptin-54 trial’s neural, physiological and behavioral findings into their correct clinical context.","date":"2026-11-07"},{"title":"Kisspeptin and mood: why a laboratory finding is not a depression treatment","url":"https://kisspeptinco.com/research-guides/kisspeptin-mood-emotion-healthy-volunteer-study","description":"Interpret the healthy-volunteer emotional-processing experiment without transferring its result to a psychiatric indication.","date":"2026-11-07"},{"title":"Kisspeptin in PCOS research: a response in some participants is not a general treatment","url":"https://kisspeptinco.com/research-guides/kisspeptin-pcos-ovulation-pilot","description":"Interpret the small exploratory ovulation study with its mixed results and preclinical boundaries intact.","date":"2026-11-07"},{"title":"Does a first kisspeptin response persist with repeated exposure?","url":"https://kisspeptinco.com/research-guides/kisspeptin-repeated-exposure-desensitization","description":"Read the hypothalamic-amenorrhea study on desensitization without turning it into a cycling or dosing protocol.","date":"2026-11-07"},{"title":"Kisspeptin safety: the questions a short trial cannot settle","url":"https://kisspeptinco.com/research-guides/kisspeptin-safety-route-evidence-questions","description":"Evaluate route-specific uncertainty, limited safety observations and the documentation needed to understand a kisspeptin claim.","date":"2026-11-07"},{"title":"Kisspeptin-10 and kisspeptin-54: why the number matters","url":"https://kisspeptinco.com/research-guides/kisspeptin-ten-versus-fifty-four","description":"Match the peptide form, delivery route and outcome to the research before applying a kisspeptin headline to a product.","date":"2026-11-07"},{"title":"Does kisspeptin raise testosterone? What an acute study can tell you","url":"https://kisspeptinco.com/research-guides/kisspeptin-testosterone-acute-versus-treatment","description":"Understand the small intravenous kisspeptin-10 experiments without turning a hormone response into a proven testosterone treatment.","date":"2026-11-07"},{"title":"Kisspeptin and women’s sexual desire: read the brain-imaging trial carefully","url":"https://kisspeptinco.com/research-guides/kisspeptin-women-desire-brain-trial","description":"What the acute kisspeptin-54 crossover study measured in women with HSDD, and what remains unanswered about lasting benefit.","date":"2026-11-07"}]}